Zim Laboratories Share Price

Zim Laboratories Share Price

NSE: ZIMLAB
|
Pharmaceuticals
|
S Cap
₹ 131.86
-₹2.09 (-1.56%)
1D
Last updated 03 Sep, 2026, 10:48 IST

Zim Laboratories Share Price Today

As of 3 Sep 2026, Zim Laboratories share price is ₹131.86. The stock opened at ₹130.00, compared to its previous close of ₹133.95. During today's trading session, Zim Laboratories share price moved in the range of ₹129.55 to ₹134.49, with an average price of ₹132.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹59.31 and a high of ₹136.90. On the performance front, Zim Laboratories share price has increased by 95.60% over the last six months and is up 76.39% on a year-on-year basis.

₹129.55
1.56% down today
₹134.49
1D LOW
1D HIGH

Zim Laboratories Returns Calculator

Circuit
L
H
₹107.16
₹160.74
52-week
L
H
₹59.31
₹136.90

About Zim Laboratories

Zim Laboratories Share Price
ISIN
INE518E01015
Sector Market Cap
₹ 638 Cr

ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.

Zim Laboratories Financial Highlights

  • Revenue: Zim Laboratories reported revenue of ₹385.78 crore in FY26 vs ₹384.81 crore in FY25. It showed an increase of 0.25% on a yearly basis.
  • Operating Profit: Zim Laboratories reported an operating profit of ₹8.21 crore in FY26 vs ₹18.01 crore in FY25. It showed a decrease of 54.41% on a year-on-year basis.
  • Net Profit: Zim Laboratories reported a net profit of ₹5.84 crore in FY26 vs ₹12.17 crore in FY25. It showed a decrease of 52.01% on a yearly basis.

Zim Laboratories Quarterly Result Highlights

  • Zim Laboratories reported revenue of ₹95.17 crore in Jun 2026, compared with ₹111.43 crore in Mar 2026, representing a decrease of 14.59% on a quarter-on-quarter (QoQ) basis.
  • Zim Laboratories reported an operating loss of ₹5.57 crore in Jun 2026, compared with ₹4.94 crore in Mar 2026, representing a decrease of 212.75% on a quarter-on-quarter (QoQ) basis.
  • Zim Laboratories reported a loss of ₹4.02 crore in Jun 2026, compared with ₹3.74 crore in Mar 2026, reflecting a decrease of 207.49% on a QoQ basis.
  • The earnings per share (EPS) of Zim Laboratories stood at ₹1.19 during Jun 2026.
Know more
Promoters
30.36%
FII
0.03%
Other DII
0.27%
Retail and other
68.28%
Mutual funds
1.07%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.02%
Mar 20260.00%
Jun 20260.03%
Mkt Cap Cr
638.00
P/E
193.62
P/B
2.44
ROE
1.97%
D/E
0.44
ROCE
5.07%
Div. Yield
0.00%
EPS(TTM)
1.22
Turnover
0.75
EV/EBITDA
18.31
Net Margin
1.19%
Op. Margin
10.37%
ROA
0.69%
Quick Ratio
0.85
Curr. Ratio
2.48
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Zim Laboratories outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Zim Laboratories appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Zim Laboratories earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Zim Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹374.40₹379.03₹367.42₹398.53
Other Income₹11.38₹5.78₹5.18₹6.41
Total Revenue₹385.78₹384.82₹372.61₹404.94
Total Expenses₹377.57₹366.81₹348.97₹369.59
Profit Before Tax₹8.21₹18.01₹23.64₹35.36
Tax₹2.37₹5.84₹6.40₹10.92
Profit After Tax₹5.84₹12.17₹17.25₹24.43
EPS - Basic₹1.19₹2.50₹3.54₹5.01
EPS - Diluted₹1.19₹2.50₹3.54₹5.01

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.21₹18.01₹23.64₹35.36
Income before WC changes₹37.31₹51.64₹45.65₹57.51
Change in Assets-₹7.30-₹5.21-₹34.69₹24.27
Change in Liabilities₹23.26-₹6.36₹7.91-₹37.11
Change in WC₹15.96-₹11.57-₹26.79-₹12.84
Cash flow from Operations₹49.53₹41.15₹16.28₹37.52
Cash flow from Investing-₹56.35-₹39.93-₹73.01-₹36.20
Cash flow from Financing₹28.19-₹9.10₹59.53₹0.55
Total Cash Flow₹23.18-₹7.65₹3.18₹3.00
Cash (Start of the year)₹1.95₹9.60₹6.42₹3.42
Cash (End of the year)₹25.12₹1.95₹9.60₹6.42

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹263.58₹240.97₹219.17₹150.63
Current Assets₹275.81₹231.31₹227.65₹190.95
Total Assets₹539.39₹472.27₹446.82₹341.58
Current Liabilities₹190.39₹166.36₹159.43₹110.79
Net Current Asset₹85.42₹64.94₹68.22₹80.16
Non-Current Liabilities₹52.84₹53.67₹48.65₹30.45
Equity Capital₹296.15₹252.24₹238.75₹200.35
Total Equity & Liabilities₹539.39₹472.27₹446.82₹341.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹370.48₹375.64₹365.47₹396.53
Other Income₹11.39₹5.62₹4.69₹6.43
Total Revenue₹381.87₹381.26₹370.16₹402.96
Total Expenses₹373.47₹363.64₹347.12₹367.04
Profit Before Tax₹8.40₹17.61₹23.04₹35.92
Tax₹2.44₹5.87₹6.28₹10.91
Profit After Tax₹5.97₹11.74₹16.76₹25.01
EPS - Basic₹1.22₹2.41₹3.44₹5.13
EPS - Diluted₹1.22₹2.41₹3.44₹5.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.40₹17.61₹23.04₹35.92
Income before WC changes₹36.10₹50.28₹44.40₹56.73
Change in Assets₹4.59-₹5.50-₹41.53₹22.54
Change in Liabilities₹10.56₹4.53₹11.17-₹37.06
Change in WC₹15.16-₹0.97-₹30.36-₹14.52
Cash flow from Operations₹47.66₹50.60₹11.47₹35.23
Cash flow from Investing-₹57.41-₹41.31-₹71.94-₹35.21
Cash flow from Financing₹28.19-₹9.10₹59.53₹0.55
Total Cash Flow₹18.43₹0.19-₹0.94₹0.57
Cash (Start of the year)₹0.36₹0.17₹1.11₹0.54
Cash (End of the year)₹18.80₹0.36₹0.17₹1.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹272.77₹248.04₹224.79₹156.23
Current Assets₹252.43₹216.35₹217.71₹178.64
Total Assets₹525.20₹464.39₹442.50₹334.87
Current Liabilities₹186.01₹166.20₹161.90₹110.24
Net Current Asset₹66.42₹50.15₹55.82₹68.40
Non-Current Liabilities₹52.84₹53.67₹48.65₹30.45
Equity Capital₹286.35₹244.51₹231.95₹194.18
Total Equity & Liabilities₹525.20₹464.39₹442.50₹334.87
* All values are in INR Crore
Qty
Bid
116
131.72
29
131.65
1172
131.6
47
131.38
51
131.35
Ask
Qty
131.91
16
131.92
9
131.99
25
132.09
11
132.1
1612
Bid Total: 1415
Ask Total: 1673
Buy orders: 46%
Sell orders: 54%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
66.64
Neutral
ATR (14)
7.49
Neutral
STOCH(9,6)
85.71
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
29.13
Bearish
UO(9)
59.17
Neutral
ROC(12)
16.28
Bullish
WillR(14)
-9.58
Bearish
Period
Simple value
Exponential vaue
5D
125.05
125.95
10D
124.64
123.69
20D
118.41
120.8
50D
118.53
116.38
100D
108.67
108.15
Volume trend — traded volume by day
3 Sep0L
2 Sep6L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average1L
Compare against other stocks
Zim Laboratories Share Price
Zim Laboratories
Pharmaceuticals
Add Stock
Add Another

Zim Laboratories Share Price FAQs